Global CNS Biomarker Market Analysed in New Occams Report Published at MarketPublishers.com
19 Nov 2015 • by Natalie Aster
LONDON – The size of the global market for the CNS biomarkers is anticipated to increase considerably, at a solid CAGR through to 2021.
In the current scenario, the R&D in the CNS market has increased owing to support from private players and government alike. In addition, FDA approvals are leading to significant scope in the biomarker market. Furthermore, technological advances in the CNS biomarker diagnostics and innovations giving rise to the CNS biomarker market expansion and growth. To date, the global CNS biomarker market is going through fast-paced expansion with the discovery of novel applications and the evolution of current technologies. The key driving the CNS biomarker market include the development in genomics, proteomics and imaging system in CNS biomarkers. Increase in government expenditure and/or private investment in health care budgets and R&D, respectively, lead to a rise of lifestyle related diseases. High costs of CNS biomarker tests and diagnostics are among the factors hindering the growth of CNS biomarker marketplace.
Abastar MDX Inc., EKF Diagnostics Holdings Inc., Aposense, Banyan biomarkers, Exonhit Therapeutics, Genenews Ltd, Great Lakes Neurotechnologies, Innogenetics Biological, Metabolon Inc., Myriad RBM Inc., Oligomerix Inc, Ridge Diagnostics, among others, are the leading players in the market.
New market study “Global Central Nervous System (CNS) Biomarkers by Country (United States, Canada, India, China, Japan, United Kingdom), Company Profiles, Share, Trends, Analysis, Opportunities, Segmentation and Forecast 2015 – 2021” elaborated by Occams Business Research (Occams) offers an extensive analysis of the global CNS biomarker sector. The report offers a comprehensive assessment of the market, covering such aspects as definition, key parameters and findings, key market insights, R&D scenario in the market, competitive intelligence, value chain analysis, key buying criteria, and strategic recommendations. The report identifies and canvasses major market drivers and stumbling blocks, opportunities and challenges. It also provides detailed market segmentation based on type, application, and by end user. A granular analysis of the market by key geographies is included, too. The report offers historical data, revenue forecasts and growth rates through 2021. Additionally, top company profiles are available in the report.
Global Central Nervous System (CNS) Biomarkers by Country (United States, Canada, India, China, Japan, United Kingdom), Company Profiles, Share, Trends, Analysis, Opportunities, Segmentation and Forecast 2015 – 2021
Published: November, 2015
Price: US$ 4,000.00
More reports by the publisher can be found at Occams page.